Repurposed drug may extend survival in aggressive ovarian cancer, trial shows

Apr 10, 2026, 8:25 PM

Relacorilant, typically used to treat Cushing’s syndrome, could improve outcomes in platinum-resistant cases...

Redirecting to full article...